Literature DB >> 12962691

Hepatic glucose metabolism in humans--its role in health and disease.

Michael Roden1, Elisabeth Bernroider.   

Abstract

The liver is mainly responsible for maintaining normal concentrations of blood glucose by its ability to store glucose as glycogen and to produce glucose from glycogen breakdown or gluconeogenic precursors. During the last decade, new techniques have made it possible to gain further insight into the turnover of hepatic glucose and glycogen in humans. Hepatic glycogen varies from approximately 200 to approximately 450 mM between overnight fasted and postprandial conditions. Patients with type-1 diabetes (T1DM), type 2 diabetes (T2DM) or partial agenesis of the pancreas exhibit increased endogenous glucose production and synthesize only 25-45% of hepatic glycogen compared with non-diabetic humans. This defect can be partly restored in T1DM by combined long- and short-term optimized treatment with insulin. In T2DM, increased gluconeogenesis was identified as the main cause of elevated glucose production and fasting hyperglycaemia. These patients also exhibit augmented intracellular lipid accumulation which could hint at a link between deranged glucose and lipid metabolism in insulin-resistant states.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12962691     DOI: 10.1016/s1521-690x(03)00031-9

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  34 in total

Review 1.  Signalling mechanisms linking hepatic glucose and lipid metabolism.

Authors:  M O Weickert; A F H Pfeiffer
Journal:  Diabetologia       Date:  2006-05-23       Impact factor: 10.122

2.  Hepatic glucose production and insulin resistance.

Authors:  Michael Roden
Journal:  Wien Med Wochenschr       Date:  2008

3.  Effect of Rebaudioside A, a diterpenoid on glucose homeostasis in STZ-induced diabetic rats.

Authors:  Ramalingam Saravanan; Kaliyappan Vengatash babu; Vinayagam Ramachandran
Journal:  J Physiol Biochem       Date:  2012-02-29       Impact factor: 4.158

4.  Assessment of anti-diabetic activity of peanut shell polyphenol extracts.

Authors:  Xiao-Meng Sun; Hai-Qing Ye; Jing-Bo Liu; Lei Wu; Ding-Bo Lin; Ya-Li Yu; Feng Gao
Journal:  J Zhejiang Univ Sci B       Date:  2018 Oct.       Impact factor: 3.066

Review 5.  Expression and function of myostatin in obesity, diabetes, and exercise adaptation.

Authors:  David L Allen; Dustin S Hittel; Alexandra C McPherron
Journal:  Med Sci Sports Exerc       Date:  2011-10       Impact factor: 5.411

6.  Histopathological findings of the pancreas, liver, and carbohydrate metabolizing enzymes in STZ-induced diabetic rats improved by administration of myrtenal.

Authors:  Ayyasamy Rathinam; Leelavinothan Pari; Ramasamy Chandramohan; Bashir Ahmad Sheikh
Journal:  J Physiol Biochem       Date:  2014-10-08       Impact factor: 4.158

Review 7.  The role of hepatokines in metabolism.

Authors:  Norbert Stefan; Hans-Ulrich Häring
Journal:  Nat Rev Endocrinol       Date:  2013-01-22       Impact factor: 43.330

8.  Streptozotocin-induced diabetes partially attenuates the effects of a high-fat diet on liver and brain fatty acid composition in mice.

Authors:  Beth Levant; Marlies K Ozias; Brianne L Guilford; Douglas E Wright
Journal:  Lipids       Date:  2013-07-28       Impact factor: 1.880

9.  Central administration of resveratrol improves diet-induced diabetes.

Authors:  Giorgio Ramadori; Laurent Gautron; Teppei Fujikawa; Claudia R Vianna; Joel K Elmquist; Roberto Coppari
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

10.  A high oleic sunflower oil fatty acid esters of plant sterols mixed with dietary diacylglycerol reduces plasma insulin and body fat accumulation in Psammomys obesus.

Authors:  Ehud Ziv; Natan Patlas; Rony Kalman; Dori Pelled; Yael Herzog; Tali Dror; Tzafra Cohen
Journal:  Lipids Health Dis       Date:  2009-10-12       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.